About this trial
Exploring the effect of supplementation with daily addition of prebiotic dried chicory root (WholeFiberTM) for 6 weeks on fecal SCFA levels, gut microbial composition and immune cell composition in minimal stage II A melanoma patients following surgical treatment.
Eligibility criteria
Qualifiers
Age ≥18 years;
The participant understands the study and can provide written informed consent;
The participant received surgical treatment of an intermediate to high-risk cutaneous melanoma (T2a/N1, T2b, T3a, T3b, T4a, T4b, N0 or N+, M0 stadium without evidence of disease);
Being able to read and speak Dutch;
Disqualifiers
Receiving concurrent adjuvant treatment, adjuvant treatment after the study period is allowed.
Having a medical history that may impact study outcomes, such as a diagnosis of diabetes mellitus type 2, heart disease, renal disease, autoimmune disease;
Any clinically significant or unstable medical disorder involving the gut, including celiac disease, inflammatory bowel disease, short-bowel syndrome or acute/chronic pancreatitis;
Having an ileostomy or colostomy, as this greatly impacts bowel function and gut microbial composition;
Trial design
Treatments tested in this trial
- prebiotic dried chicory root (WholeFiber)